Tag: Tech

Home Tech
Post

India Formalises Deep-Tech Startup Definition, Extends Recognition to 20 Years – ciol.com

0By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.Don’t have an account? Signup Powered by : Follow UsThe Indian government has, for the first time, formally defined deep-tech startups, expanding the scope of benefits available to research-intensive...

Post

New surgical infection drug from PolyPid heads to FDA decision in 2027 – Stock Titan

Datavault AI Signs $2.0 Billion Structured Financing Term Sheet W…Robo.ai Announces Completion of 100% Acquisition of Neurovia AI, …Sphere 3D and Cathedra Bitcoin Announce Closing of Business Combi…Hyperscale Data Subsidiary Ault Global Commodities Enters into Ag…NUBURU Expands Defense & Security Platform Momentum with Tier-One…Optimum Launches Effort to Drive a Consensual Repositioning of it…Datavault AI Signs...

Post

Revolut Cracks India with 450K Waitlist Ahead of Full Launch – The Tech Buzz

Your premier source for technology news, insights, and analysis. Covering the latest in AI, startups, cybersecurity, and innovation.Get the latest technology updates delivered straight to your inbox.Reach 1.1M+ subscribers via TechBuzz Press.Send us a tip using our anonymous form.Reach out to us on any subject.© 2026 The Tech Buzz. All rights reserved.Revolut Cracks India with...

Post

Raptee.HV becomes first EV motorcycle OEM to secure TDB funding – ET Auto

News See whats happening in Automobile Industry right now Exclusive Breaking, In-depth & Industry Inside Stories Leaders Speak Business leaders sharing their insights Events Auto Events- Explore and discuss challenges & trends in India’s leading B2B Auto events Awards Recognise work that not only stood out but was also purposeful Webinars Join leaders & experts...

Post

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg) – Yahoo Finance Singapore

Something went wrongISELIN, N.J., June 01, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced the resubmission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ONS-5010/LYTENAVA™...